These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1433192)
21. An efficient synthesis of a hydroxyethylamine (HEA) isostere and its α-aminophosphonate and phosphoramidate derivatives as potential anti-HIV agents. Bhattacharya AK; Rana KC; Pannecouque C; De Clercq E ChemMedChem; 2012 Sep; 7(9):1601-11. PubMed ID: 22786810 [TBL] [Abstract][Full Text] [Related]
22. Modified oligopeptides designed to interact with the HIV-1 proteinase inhibit viral replication. Grinde B; Hungnes O; Tjøtta E Arch Virol; 1990; 114(3-4):167-73. PubMed ID: 2241573 [TBL] [Abstract][Full Text] [Related]
23. Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency. Klabe RM; Bacheler LT; Ala PJ; Erickson-Viitanen S; Meek JL Biochemistry; 1998 Jun; 37(24):8735-42. PubMed ID: 9628735 [TBL] [Abstract][Full Text] [Related]
24. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Rudensey LM; Kimata JT; Benveniste RE; Overbaugh J Virology; 1995 Mar; 207(2):528-42. PubMed ID: 7886956 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of potent C(2)-symmetric, diol-based hiv-1 protease inhibitors. Investigation of thioalkyl and thioaryl P1/P1' substituents. Mühlman A; Classon B; Hallberg A; Samuelsson B J Med Chem; 2001 Oct; 44(21):3402-6. PubMed ID: 11585445 [TBL] [Abstract][Full Text] [Related]
26. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic. Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid. Marastoni M; Fantin G; Bortolotti F; Tomatis R Arzneimittelforschung; 1996 Nov; 46(11):1099-101. PubMed ID: 8955873 [TBL] [Abstract][Full Text] [Related]
28. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere. Beaulieu PL; Wernic D; Abraham A; Anderson PC; Bogri T; Bousquet Y; Croteau G; Guse I; Lamarre D; Liard F; Paris W; Thibeault D; Pav S; Tong L J Med Chem; 1997 Jul; 40(14):2164-76. PubMed ID: 9216835 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of di- and tripeptide analogues containing alpha-ketoamide as a new core structure for inhibition of HIV-1 protease. Sheha MM; Mahfouz NM; Hassan HY; Youssef AF; Mimoto T; Kiso Y Eur J Med Chem; 2000 Oct; 35(10):887-94. PubMed ID: 11121614 [TBL] [Abstract][Full Text] [Related]
30. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms. Korth MJ; Taylor MD; Katze MG Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919 [TBL] [Abstract][Full Text] [Related]
31. Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. Chen X; Kempf DJ; Sham HL; Green BE; Molla A; Korneyeva M; Vasavanonda S; Wideburg NE; Saldivar A; Marsh KC; McDonald E; Norbeck DW Bioorg Med Chem Lett; 1998 Dec; 8(24):3531-6. PubMed ID: 9934466 [TBL] [Abstract][Full Text] [Related]
32. Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substrates. Dukes CS; Matthews TJ; Lambert DM; Dreyer GB; Petteway SR; Weinberg JB AIDS Res Hum Retroviruses; 1996 Jun; 12(9):777-82. PubMed ID: 8738429 [TBL] [Abstract][Full Text] [Related]
33. The synthesis of novel HIV-protease inhibitors. Girijavallabhan VM; Bennett F; Patel NM; Ganguly AK; Dasmahapatra B; Butkiewicz N; Hart A Bioorg Med Chem; 1994 Oct; 2(10):1075-83. PubMed ID: 7773624 [TBL] [Abstract][Full Text] [Related]
34. 2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors. Beaulieu PL; Anderson PC; Cameron DR; Croteau G; Gorys V; Grand-Maître C; Lamarre D; Liard F; Paris W; Plamondon L; Soucy F; Thibeault D; Wernic D; Yoakim C; Pav S; Tong L J Med Chem; 2000 Mar; 43(6):1094-108. PubMed ID: 10737742 [TBL] [Abstract][Full Text] [Related]
35. HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells. Pettit SC; Sanchez R; Smith T; Wehbie R; Derse D; Swanstrom R AIDS Res Hum Retroviruses; 1998 Jul; 14(11):1007-14. PubMed ID: 9686647 [TBL] [Abstract][Full Text] [Related]
36. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. Thanki N; Rao JK; Foundling SI; Howe WJ; Moon JB; Hui JO; Tomasselli AG; Heinrikson RL; Thaisrivongs S; Wlodawer A Protein Sci; 1992 Aug; 1(8):1061-72. PubMed ID: 1304383 [TBL] [Abstract][Full Text] [Related]